EPISODE · May 20, 2026 · 7 MIN
Is HRR really a biomarker in prostate cancer?
from PharmOncology · host Ming-Hei Tai
Why HRR gene mutations are not the perfect biomarker. PROpel trial: thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00382-0/fulltextTALAPRO-2 trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00684-1/abstractTRITON-3 trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2214676
What this episode covers
Why HRR gene mutations are not the perfect biomarker. PROpel trial: thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00382-0/fulltextTALAPRO-2 trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00684-1/abstractTRITON-3 trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2214676
NOW PLAYING
Is HRR really a biomarker in prostate cancer?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.